1. Home
  2. BHVN vs PTVE Comparison

BHVN vs PTVE Comparison

Compare BHVN & PTVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • PTVE
  • Stock Information
  • Founded
  • BHVN 2013
  • PTVE 1880
  • Country
  • BHVN United States
  • PTVE United States
  • Employees
  • BHVN N/A
  • PTVE N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • PTVE Containers/Packaging
  • Sector
  • BHVN Health Care
  • PTVE Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • PTVE Nasdaq
  • Market Cap
  • BHVN 2.9B
  • PTVE 3.2B
  • IPO Year
  • BHVN 2017
  • PTVE 2020
  • Fundamental
  • Price
  • BHVN $27.65
  • PTVE $17.96
  • Analyst Decision
  • BHVN Strong Buy
  • PTVE Hold
  • Analyst Count
  • BHVN 14
  • PTVE 6
  • Target Price
  • BHVN $63.15
  • PTVE $16.50
  • AVG Volume (30 Days)
  • BHVN 1.2M
  • PTVE 667.7K
  • Earning Date
  • BHVN 03-03-2025
  • PTVE 05-01-2025
  • Dividend Yield
  • BHVN N/A
  • PTVE 2.23%
  • EPS Growth
  • BHVN N/A
  • PTVE N/A
  • EPS
  • BHVN N/A
  • PTVE N/A
  • Revenue
  • BHVN N/A
  • PTVE $5,148,000,000.00
  • Revenue This Year
  • BHVN N/A
  • PTVE $3.94
  • Revenue Next Year
  • BHVN $65.26
  • PTVE $2.82
  • P/E Ratio
  • BHVN N/A
  • PTVE N/A
  • Revenue Growth
  • BHVN N/A
  • PTVE N/A
  • 52 Week Low
  • BHVN $26.57
  • PTVE $8.83
  • 52 Week High
  • BHVN $55.72
  • PTVE $17.98
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 35.77
  • PTVE 75.79
  • Support Level
  • BHVN $28.22
  • PTVE $17.94
  • Resistance Level
  • BHVN $31.18
  • PTVE $17.98
  • Average True Range (ATR)
  • BHVN 1.56
  • PTVE 0.03
  • MACD
  • BHVN 0.20
  • PTVE -0.00
  • Stochastic Oscillator
  • BHVN 23.43
  • PTVE 86.67

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About PTVE Pactiv Evergreen Inc. Common stock

Pactiv Evergreen Inc is engaged in the business of manufacturing and distributing fresh foodservice and food merchandising products and fresh beverage cartons. It operates in two segments: Foodservice, Food and Beverage Merchandising. These segments manufacture products such as food containers, drinkware, tableware, service ware, ready-to-eat food containers, clear rigid-display containers, trays for meat and poultry, molded fiber egg cartons, printed cartons, spouts & filling machines, and other products. It generates the majority of its revenue from Food and Beverage Merchandising. The company's geographical segments are the United States, the Rest of North America, and Others, of which the vast majority of its revenue comes from the United States.

Share on Social Networks: